Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Connect with us

Hi, what are you looking for?

slide 3 of 2
THE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & LifestyleTHE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & Lifestyle

Finance

Finance

Abbott Buys St. Jude Medical

The healthcare company Abbott Laboratories was approved for a $25 billion procurement of St. Jude Medical, who is known for its production of medical devices.

Abbott announced that it will be selling a vascular closure, used to seal small holes in the artery after a coronary, that is made by St. Jude along with its own steering device, which is used to place catheters into hearts, to a Japan-based corporation.

Abbott says that the deal with St. Jude will be a great asset when it comes to competition with other companies like Medtronic. The deal also comes at a good time when most hospitals are getting rid of many of their suppliers.

St. Jude, however, has been running into problems with its devices. St. Jude received complaints from research firm MedSec during the summer who said that devices used for the heart had many defects that allowed them to be susceptible to hackers. St. Jude denied the accusations of any defects and sued the firm. Later in the fall, St. Jude said it told doctors to cease use of pacemakers due to electric problems caused by malfunction of the battery.

On the other hand, Abbott has been doing business with Johnson and Johnson. Abbott has sold cardiovascular devices to Johnson and Johnson for an estimated $4.3 billion. Along with revamping its pharmaceutical company as AbbVie in 2013, Abbott is current attempting to withdraw from an agreement with Alere, a diagnostic maker, that is for $5.8 billion.


Comment Template

You May Also Like

Business

Starting in 2024, the IRS will lower the Form 1099-K reporting threshold to $5,000 for business transactions via payment platforms like PayPal and Venmo....

Business

The stock market saw major premarket moves on February 14, 2025. Roku and Airbnb surged on strong earnings, while Moderna and Informatica fell on...

Business

Warren Buffett’s Berkshire Hathaway trimmed its stake in DaVita amid a weaker 2025 outlook, causing an 8% stock decline. Rising costs and dialysis center...

Business

Stock futures dipped amid new trade policy shifts from President Trump, while GameStop surged on crypto investment speculation. Major retailers scaled back DEI commitments,...

Notice: The Biznob uses cookies to provide necessary website functionality, improve your experience and analyze our traffic. By using our website, you agree to our Privacy Policy and our Cookie Policy.

Ok